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Introduction
The convenience of modern air travel has allowed us accessibility to
virtually all parts of the world. Individuals may now be exposed to
endemic diseases both where they live and where they travel. The
modem physician must include in their differential diagnosis dis
eases not only endemic to their locale, but also of those places where
patients have visited or are traveling from. Coccidioidomycosis is
a fungal infection endemic in the southwestern United States,
northern Mexico and certain areas of Central and South America.
Presentation of coccidioidal disease can range from asymptomatic
to disseminated and life-threatening. Symptomatic acute disease
occurs in about 40% of patients, lasting a few weeks and resolving
without specific therapy. Chronic disease is rare and may be limited
to the lung, manifested by cavitary lesions or slow, progressive
disease. Our patient was a long-term resident of Arizona who
presented with coccidioidomycosis while vacationing in Hawaii.
We describe this presentation of coccidioidomycosis in a traveler
and long-term resident of Arizona. His presentation was one of
persistent pulmonary coccidioidomycosis, an uncommon form of
this mycosis.
Case Report
A previously healthy 76 year old Caucasian male vacationing in
Hawaii from Arizona presented to our facility with a six week
history of documented fever to 103 degrees Farenheit. chills, night
sweats, decreased appetite, and a sixteen pound weight loss. He had
been on the Island of Oahu for 2 days prior to admission. He was
previously treated in Arizona with a ten day course of erythromycin
for presumed bacterial bronchitis. His history was also notable for
twenty pack years of tobacco use. Physical exam was notable for
clear lung fields bilaterally with decreased breath sounds in the right
upper lobe and no wheezes. Chest radiograph revealed a patchy
right upper lobe infiltrate (Figure 1). Laboratory evaluation re
vealed a leukocytosis of 17,000 white blood cells (WBC)/FL asso
ciated with 74% granulocytes, and eosinophilia of 1400 cells/FL.
Computed tomography of the chest revealed extensive airspace
consolidation of the right upper lobe with several large bullae and
calcified granulomas (Figure 2). Lymph nodes were noted in the
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Figure 2.— Chest Computed Tomography
right hilar, peritracheal, and subcarinal regions. Sputum cultures
recovered Coccidioides irninitis. Mycobacterial smear and culture
of sputum was negative.
This information led to further evaluation by lumbar puncture.
Cerebrospinal fluid (CSF) analysis revealed normal glucose, no
WBCs. no organisms on gram stain and fungal smear, and negative
C’occidioides antibody. Serum Coccidioides antibody was positive.
The patient was diagnosed with pulmonary coccidioidomycosis
with underlying chronic obstructive pulmonary disease (COPD).
Therapy with oral fluconazole 400 mg once daily was initiated.
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Figure 1.— Chest Radiograph
During his six day hospital course, he responded well to this regimen
with a defervescence, normalizing leukocytosis and no oxygen
requirement. He was discharged home, returning to Arizona several
weeks after his hospitalization. He was monitored with serial
Coccidioides antibody testing. At two months follow up this test
became negative. Repeat testing four months later confirmed
negative findings and therapy was discontinued. The patient com
pleted six months of treatment and was completely symptom free
upon telephonic follow up one month after cessation of therapy.
Discussion
Coccidioidomycosis is most commonly thought of as a disease of
Texas, Arizona, and southern California.’ Presentation of this
mycosis outside its endemic area is not unusual, but frequently
remains underdiagnosed. An adequate travel history is essential.
Primary coccidioidomycosis presents with minimal or absent symp
toms in 60% of patients.23 The remaining 40% most frequently
present with a febrile pulmonary illness that resembles influenza.
Symptoms include nonproductive cough, fever, fatigue, and pleu
ritic chest pain, a syndrome referred to as “valley fever”. Symptoms
of dyspnea, arthralgias, myalgias and cutaneous eruptions (includ
ing erytherma nodosum and erythema multiforme) have also been
noted. Pulmonary infiltrates may be accompanied by hilar adenopa
thy or pleural effusion. Most cases (95%) of acute infection resolve
without therapy. Chronic progressive coccidioidal pneumonia is a
less common form of the mycosis that can evolve directly from
primary pulmonary coccidioidomycosis or develop years after ac
quisition of primary infection. Chronic infections tend to be
indolent with slow progression of pulmonary destruction but are not
likely to disseminate to distaiit organs. Persistent or recurrent fever
in severe primary illness can signal the onset of disseminated
diseases. This form may progress rapidly or slowly as bone andjoint
infection, skin disease, soft tissue abscesses, or meningitis. Menin
gitis is important to rule out in all infected patients. because
untreated, death results in up to 90% of this group of patients.’
Our patient’s illness does not meet published criteria for acute or
chronic infection. ‘ His presentation is not acute because the
duration of symptoms persisted longer than one to three weeks. His
disease is not consistent with chronic pulmonary or disseminated
infection because typical lung findings or evidence ofdissemination
were not present. Rather, his presentation is more consistent with
persistent pulmonary coccidioidomycosis •24 This syndrome has
been reported in small numbers of cases characterized by symptoms
of primary infection lasting beyond six weeks. Symptoms include
low-grade fever, anorexia, weight loss, cough, and chest pain
frequently accompanied by a chest radiograph that fails to show
either progression or resolution of abnormalities. This syndrome
likely represents a step in the progression of some patients to chronic
pulmonary disease. Untreated, this syndrome can be fatal.
Treatment of coccidioidomycosis is seldom indicated in primary
pulmonary coccidioidomycosis ofmild to moderate severity. Therapy
should be considered in patients whose immune status or racial!
ethnic background places them at high risk of dissemination. These
patient categories include: immunosuppressed patients, diabetics.
pregnant women, and black and Filipino males.5 Treatment is also
advised when a primary pulmonary infection is persistent or
progressive, as it was in our patient. Effective antifungal agents
include amphotericin B and the azole antifungal agents ketoconazole,
itraconazole, and fluconazole.6Amphotericin B is recommended in
patients with life-threatening disease, usually manifested by respi
ratory compromise, rapid deterioration, or any meningeal involve
ment. Oral azole agents are often selected for those with chronic
processes. There are no comparative studies demonstrating the
superiority of one azole antifungal over another, but ketoconazole is
the only orally available agent that is approved for this infection.’
Clinical trials have indicated that fluconazole and itraconazole are
both efficacious in moderate and chronic infection. Because of its
good penetration into the CSF, fluconazole is life-saving in the
chronic treatment of coccidioidal meningitis.
Our patient is interesting in that he presented with an uncommon
form of coccidioidomycosis outside of the endemic area. His
syndrome did not clearly fit the classic description of either acute or
chronic pulmonary coccidioidomycosis, but rather an intermediate
syndrome. Previously undiagnosed COPD likely played a role in his
protracted pulmonary infection and placed him at risk for chronic
infection. The health care provider must take into consideration the
patient’s origin and travel in forming a differential diagnosis. As
demonstrated in this case, inclusion of origin or travels can assist in
the diagnosis of both common and rare forms of endemic infections
outside of their areas of endemicity.
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